DE602004016732D1 - Zusammensetzungen und verfahren zur diagnose und behandlung einer entzündung - Google Patents

Zusammensetzungen und verfahren zur diagnose und behandlung einer entzündung

Info

Publication number
DE602004016732D1
DE602004016732D1 DE602004016732T DE602004016732T DE602004016732D1 DE 602004016732 D1 DE602004016732 D1 DE 602004016732D1 DE 602004016732 T DE602004016732 T DE 602004016732T DE 602004016732 T DE602004016732 T DE 602004016732T DE 602004016732 D1 DE602004016732 D1 DE 602004016732D1
Authority
DE
Germany
Prior art keywords
inflammation
diagnosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004016732T
Other languages
English (en)
Inventor
Nathan Karin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rappaport Family Institute for Research in the Medical Sciences
Original Assignee
Rappaport Family Institute for Research in the Medical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32994504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004016732(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rappaport Family Institute for Research in the Medical Sciences filed Critical Rappaport Family Institute for Research in the Medical Sciences
Publication of DE602004016732D1 publication Critical patent/DE602004016732D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004016732T 2003-03-12 2004-03-14 Zusammensetzungen und verfahren zur diagnose und behandlung einer entzündung Expired - Lifetime DE602004016732D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45351203P 2003-03-12 2003-03-12
US45351403P 2003-03-12 2003-03-12
PCT/IL2004/000241 WO2004080385A2 (en) 2003-03-12 2004-03-14 Compositions and methods for diagnosing and treating an inflammation

Publications (1)

Publication Number Publication Date
DE602004016732D1 true DE602004016732D1 (de) 2008-11-06

Family

ID=32994504

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016732T Expired - Lifetime DE602004016732D1 (de) 2003-03-12 2004-03-14 Zusammensetzungen und verfahren zur diagnose und behandlung einer entzündung

Country Status (4)

Country Link
EP (1) EP1601374B2 (de)
AT (1) ATE409046T1 (de)
DE (1) DE602004016732D1 (de)
WO (1) WO2004080385A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004013554D1 (de) 2003-03-12 2008-06-19 Rappaport Family Inst For Res Verbindungen und verfahren zur diagnose von prostatakrebs
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
JP5565906B2 (ja) * 2007-04-16 2014-08-06 ヘルス リサーチ インコーポレイテッド スカベンジャー受容体−ａを抑制する方法および抗原への免疫応答を増大する方法
JP2010534335A (ja) 2007-07-24 2010-11-04 アイエスエス イミューン システム スティミュレーション アーベー 全身性エリテマトーデス感受性を予測するための方法及び手段
JP6322209B2 (ja) * 2012-12-18 2018-05-09 ビオクリネ エービー 糖尿病の治療および／または発症抑制のための方法
US20170274001A1 (en) * 2014-09-08 2017-09-28 Yale University Compositions and Methods for Increasing Red Blood Cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529898A (en) * 1993-08-19 1996-06-25 Duke University Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors
US6429289B1 (en) * 1994-06-23 2002-08-06 Massachusetts Institute Of Technology Class BI and CI scavenger receptors
WO1999011288A1 (en) * 1997-09-05 1999-03-11 Massachusetts Institute Of Technology Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction
EP1558275A4 (de) † 2002-10-30 2009-06-24 Us Health Scavenger-rezeptor b1 (cla-1) targeting zurbehandlung von infektionen, sepsis und entz ndungen

Also Published As

Publication number Publication date
EP1601374A4 (de) 2006-06-28
WO2004080385A2 (en) 2004-09-23
EP1601374B1 (de) 2008-09-24
WO2004080385A3 (en) 2005-08-04
EP1601374B2 (de) 2012-05-23
ATE409046T1 (de) 2008-10-15
EP1601374A2 (de) 2005-12-07

Similar Documents

Publication Publication Date Title
ATE464323T1 (de) Zusammensetzungen und verfahren für die tumor- diagnose und behandlung
EA200700251A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
CZ2006579A3 (cs) Kožní mikroaktivační systém
DE602004020332D1 (de) Neue heterozyklische verbindungen, die sich für die behandlung von entzündlichen und allergischen erkrankungen eignen: verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
DE60108230D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE602005002745D1 (de) Medizinische vorrichtungen und verfahren zu ihrer herstellung
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
CO5710194A1 (es) Composiciones de cuidado oral, dispositivos, y metodos de uso de las mismas
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE470354T1 (de) Systeme und verfahren für die ex-vivo-organpflege
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
NO20054336D0 (no) Blandinger og fremgangsmate for diagnostisering og behandling av astma eller andre allergiske eller inflammatoriske sykdommer
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
ATE445389T1 (de) Liposomale glucocorticoide
DE602004017481D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
ATE494296T1 (de) Zusammensetzungen und verfahren für die tumordiagnose und behandlung
ATE413399T1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen
WO2008027611A3 (en) Compositions for visualization of vitreous body and methods of using same
DE602004016732D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung einer entzündung
DE60335083D1 (de) Derivate von alpha-phenylthiocarbon- und alpha-phenyloxycarbonsäuren, die für die behandlung von auf die aktivierung von ppar alpha ansprechende krankheiten geeignet sind
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen

Legal Events

Date Code Title Description
8363 Opposition against the patent